Information about the healthcare providers and facilities involved with the investigation, treatment, and care of patients with suspected or confirmed COVID-19 are usually recorded in electronic health records. The monitoring of medical equipment availability at healthcare facilities, such as Personal Protective Equipment (PPE) and respiratory devices, is also of utmost importance during the COVID-19 pandemic. Relevant details, which can be recorded using SNOMED CT include:
Healthcare profession
Site of care
Health management finding
Personal protective equipment
These data elements are described below, with example SNOMED CT subsets for each.
The healthcare profession is the occupation or qualification of the healthcare provider who is involved in the investigation, treatment, care or education of the patient - for example or .
CV19-PFD-HealthcareProfession Intensional Definition : <
The site of care refers to the location of the specific investigation, treatment or care setting - for example , , or .
CV19-PFD- SiteOfCare Intensional Definition : < OR << OR << OR << OR << OR <<
2.1.3 Health Management Finding
Health management finding includes concepts that describe the circumstances which affect whether the planned patient outcomes are attained, that different areas within a health organization are running appropriately, that tasks are correctly defined and assessed and that resources are used efficiently. -for example , or .
CV19-PFD- HealthManagementFinding Intensional Definition : <
Personal protective equipment is protective clothing, or other garments or equipment designed to protect the wearer's body from injury or infection - for example and
CV19-PFD- PersonalProtectiveEquipment Intensional Definition : << OR << OR << OR << OR << OR << OR << OR <<

The collection of coded COVID-19 related data can be critical for frontline service delivery, pandemic surveillance, and retrospective data analysis.
The following table lists a collection of data elements for which SNOMED CT can be used to capture COVID-19 related data.
|--- Provider and facility details([section 2.1](https://confluence.ihtsdotools.org/display/WIPCV19/2.1+Provider+and+Facility+Details?src=sidebar))|
Healthcare profession
Site of care
Health management finding
Personal protective equipment
Patient demographics
Biological sex
Gender identity
Marital or partnership status
Nationality
Clinical assessment
Symptoms
Severity
Clinical measurements
Clinical examination findings
Tests and Investigations
Specimen
Laboratory tests
Radiology procedures
Substances and virus
Prevention, treatment and education
Prevention
Prevention findings
Education
Medication
Note
The SNOMED CT subsets are provided as a guide only, and may need to be constrained or extended to meet local requirements.
Ethnic group
Racial group
Occupation
Travel history
Residential location type
Next of kin relationship
Living arrangements
Care and support circumstances
Diagnosis and certainty
Secondary conditions and complications
Potential risk factors
Comorbidities
Exposure event
Covid-19 and viral co-infections
Laboratory test results
Other investigations
Administrative procedures
Therapeutic procedures
Treatment findings
Treatment equipment

General demographic characteristics are important to record for each patient being investigated or treated for COVID-19. Relevant patient demographics, which can be recorded using SNOMED CT includes:
Biological sex
Gender identity
Marital or partnership status
Nationality
Ethnic group
Racial group
Occupation
Travel history
Residential location type
Next of kin relationship
Living arrangements
Care and support circumstances
These data elements are described below, with example SNOMED CT subsets for each.
Multiple types of sex and/or gender are recorded in clinical practice, including biological sex and gender identity. 1
SNOMED CT supports the distinction between biological sex (e.g. ) and gender identity (e.g. ), as shown in the two subset definitions below.
CV19-PAT- BiologicalSex Intensional Definition : < MINUS <<
CV19-PAT- GenderIdentity Intensional Definition : <
The marital or partnership status of a patient describes their legal, civil or personal relationship with their significant other, for example .
CV19-PAT- MaritalOrPartnershipStatus Intensional Definition : <
Nationality refers to a particular legal relationship between an individual person and a sovereign state. The nationality of a patient may refer to the nation in which they were born, have citizenship, or have other legal ties - for example or .
CV19-PAT- Nationality Intensional Definition : <
The ethnic group (or ethnicity) of a patient is the social or cultural group with whom they identify - for example, or .
CV19-PAT- EthnicGroup Intensional Definition : <
The racial group (or race) of a patient is the group (or groups) with whom they share inherited physical characteristics - for example, or .
CV19-PAT- RacialGroup Intensional Definition : <
Occupation is the patient's job or profession - for example, or .
CV19-PAT- Occupation Intensional Definition : <
The travel history of a patient is a record of their past visits to locations both inside and outside their country of residence. This may include a list of the specific countries and/or regions that they have travelled to (e.g. or ), or a descriptive travel history finding (e.g. ).
CV19-PAT-TravelHistory Intensional Definition : < OR < OR <
The residential location type is the type of place in which the patient is currently living, or was living prior to admission to hospital - for example, or .
CV19-PAT- ResidentialLocationType Intensional Definition : <
The next of kin relationship is the relationship that the patient has with their closest living relative (as chosen by the patient) - for example or .
CV19-PAT- NextOfKinRelationship Intensional Definition : <
The living arrangements of the patient describes the familial and non-familial relationships of a person to all the other people with whom they usually reside - for example or .
CV19-PAT- LivingArrangements Intensional Definition : <
The care and support circumstances of the patient describe how and by whom they are looked after when living at their usual place of residence - for example or .
CV19-PAT- CareAndSupportCircumstances Intensional Definition : <
Footnotes
1

Laboratory testing for COVID-19 and the associated SARS-CoV-2 virus includes methods that detect the presence of the virus and antibodies produced in response to infection, in specimen samples taken from potentially infected individuals. Test and investigation data which can be recorded using SNOMED CT includes:
Specimen
Laboratory Tests
Radiology Procedures
Substances and Virus
Laboratory Test Results
Other Investigations
These data elements are described below, with example SNOMED CT subsets for each.
Specimens are samples of substances taken from an individual for testing - for example or . The following specimens may be relevant to COVID-19 testing in one or more countries affected by the virus.
CV19-INV-Specimen
The specimens prefixed with a star '*' are a subtype of another member of this subset.
Laboratory tests can be performed to detect the presence of the COVID-19 virus and antibodies produced in response to this virus. The following SNOMED CT concepts can be used to record laboratory tests that may be performed during the investigation process.
CV19-INV-LaboratoryTests
Radiology procedures are procedures that obtain images of the inside of the body. The following SNOMED CT concepts may be used to record radiology procedures that may be performed during the investigation and treatment of suspected or confirmed Covid-19 patients.
CV19-INV-RadiologyProcedures
An antibody is a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. The following antibody/antigen and virus organism concepts can be used to record the focus of a COVID-19 investigation.
CV19-INV-SubstancesAndVirus
Laboratory test results are used to specify whether the Laboratory test focus was detected or not detected following the conducted laboratory test. The following qualifier values may be used for this purpose.
CV19-INV-LabTestResults
Other investigative procedures - e.g. and and and - may be performed to assess a COVID-19 patient. The following subset represents procedures that can be performed during the clinical assessment process.
The following subset represents a collection of findings with context that may be related to these investigations and captured using SNOMED CT - for example or .
Footnotes
1 , Division of Laboratory Systems, CDC, US
2 , The Native Antigen Company, UK
119297000
Blood specimen (specimen)
Blood specimen
20040731
*
258607008
Bronchoalveolar lavage fluid sample (specimen)
Bronchoalveolar lavage fluid sample
20080731
*
122554006
Capillary blood specimen (specimen)
Capillary blood specimen
20080731
*
119294007
Dried blood specimen (specimen)
Dried blood specimen
20020131
168137004
Gastric aspirate sample (specimen)
Gastric aspirate sample
20060131
258606004
Lower respiratory sample (specimen)
Lower respiratory sample
20080731
258411007
Nasopharyngeal aspirate (specimen)
Nasopharyngeal aspirate
20080731
258500001
Nasopharyngeal swab (specimen)
Nasopharyngeal swab
20080731
258412000
Oropharyngeal aspirate (specimen)
Oropharyngeal aspirate
20080731
418564007
Pleural fluid specimen (specimen)
Pleural fluid specimen
20080731
119342007
Saliva specimen (specimen)
Saliva specimen
20040731
*
119364003
Serum specimen (specimen)
Serum specimen
20050131
734427005
Specimen from duodenum obtained by aspiration (specimen)
Specimen from duodenum obtained by aspiration
20180131
122610009
Specimen from lung obtained by biopsy (specimen)
Specimen from lung obtained by biopsy
20080731
445447003
Specimen from trachea obtained by aspiration (specimen)
Specimen from trachea obtained by aspiration
20100731
119334006
Sputum specimen (specimen)
Sputum specimen
20080731
119339001
Stool specimen (specimen)
Stool specimen
20030731
*
472901003
Swab from nasal sinus (specimen)
Swab from nasal sinus
20130131
445297001
Swab of internal nose (specimen)
Swab of internal nose
20100731
*
871810001
Swab specimen from nasal mid-turbinate (specimen)
Mid-turbinate nasal swab
20200731
461911000124106
Swab specimen from oropharynx (specimen)
Oropharyngeal swab
20200731
258529004
Throat swab (specimen)
Throat swab
20080731
122877000
Upper respiratory fluid specimen obtained by tracheal aspiration (specimen)
Upper respiratory fluid specimen obtained by tracheal aspiration
20040731
309164002
Upper respiratory swab sample (specimen)
Upper respiratory swab sample
20080731
122575003
Urine specimen (specimen)
Urine specimen
20080731
*
258580003
Whole blood sample (specimen)
Whole blood sample
20080731
Analysis of arterial blood gases and pH (procedure)
Analysis of arterial blood gases and pH
20020131
444077007
Analysis using reverse transcriptase polymerase chain reaction technique (procedure)
Analysis using reverse transcriptase PCR
20100131
61911006
Blood gases, venous measurement (procedure)
Blood gases, venous measurement
20020131
871555000
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2
20200731
871559006
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in bronchoalveolar lavage fluid (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in bronchoalveolar lavage fluid
20200731
871556004
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in nasopharyngeal swab (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in nasopharyngeal swab
20200731
871557008
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in oropharyngeal swab (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in oropharyngeal swab
20200731
871558003
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in sputum (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in sputum
20200731
871560001
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction (observable entity)
Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction
20200731
871562009
Detection of Severe acute respiratory syndrome coronavirus 2 (observable entity)
Detection of Severe acute respiratory syndrome coronavirus 2
20200731
871553007
Detection of Severe acute respiratory syndrome coronavirus 2 antigen (observable entity)
Detection of Severe acute respiratory syndrome coronavirus 2 antigen
20200731
76978006
Enzyme-linked immunosorbent assay (procedure)
Enzyme-linked immunosorbent assay
20080731
30662005
Fluorescent immunoassay (procedure)
Fluorescent immunoassay
20020131
414464004
Immunoassay method (procedure)
Immunoassay method
20050131
1240461000000109
Measurement of severe acute respiratory syndrome coronavirus 2 antibody (observable entity)
Measurement of severe acute respiratory syndrome coronavirus 2 antibody
20200731
1240471000000102
Measurement of severe acute respiratory syndrome coronavirus 2 antigen (observable entity)
Measurement of severe acute respiratory syndrome coronavirus 2 antigen
20200731
122435008
Measurement of viral antibody (procedure)
Measurement of viral antibody
20100131
9718006
Polymerase chain reaction analysis (procedure)
Polymerase chain reaction analysis
20080731
122433001
Viral antigen assay (procedure)
Viral antigen assay
20050131
118147004
Viral nucleic acid assay (procedure)
Viral nucleic acid assay
20020131
88667002
Viral serologic study (procedure)
Viral serologic study
20150131
Computed tomography of chest (procedure)
CT of chest
20040731
399208008
Plain chest X-ray (procedure)
Plain chest X-ray
20050131
88628008
Ultrasonography of lung (procedure)
Ultrasonography of lung
20020131
Antigen of severe acute respiratory syndrome coronavirus 2 (substance)
Antigen of SARS-CoV-2
20200131
870361009
Immunoglobulin G antibody to Severe acute respiratory syndrome coronavirus 2 (substance)
SARS-CoV-2 IgG
20200731
870362002
Immunoglobulin M antibody to Severe acute respiratory syndrome coronavirus 2 (substance)
SARS-CoV-2 IgM
20200731
1155866009
Messenger ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 encoding spike protein (substance)
SARS-CoV-2 mRNA encoding spike protein
20210731
1119343008
Messenger ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (substance)
Severe acute respiratory syndrome coronavirus 2 mRNA
20210131
1240411000000107
Ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (substance)
Severe acute respiratory syndrome coronavirus 2 RNA
20200731
840533007
Severe acute respiratory syndrome coronavirus 2 (organism)
SARS-CoV-2
20200131
Inconclusive (qualifier value)
Inconclusive
20060131
260415000
Not detected (qualifier value)
Not detected
20020131
895231008
Not detected in pooled specimen (qualifier value)
Not detected in pooled specimen
20200731
897035006
Severe acute respiratory syndrome coronavirus 2 antibody test negative (finding)
SARS-CoV-2 antibody test negative
20210131
897034005
Severe acute respiratory syndrome coronavirus 2 antibody test positive (finding)
SARS-CoV-2 antibody test positive
20210131
1240581000000104
Severe acute respiratory syndrome coronavirus 2 detected (finding)
Severe acute respiratory syndrome coronavirus 2 detected
20200731
1240591000000102
Severe acute respiratory syndrome coronavirus 2 not detected (finding)
Severe acute respiratory syndrome coronavirus 2 not detected
20200731
125154007
Specimen unsatisfactory for evaluation (finding)
Specimen unsatisfactory for evaluation
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
*
697989009
Anterior nares swab (specimen)
Anterior nares swab
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
16332841000119106
Computed tomography angiography of pulmonary artery with contrast (procedure)
CT angiography of pulmonary artery with contrast
20170131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
840535000
Antibody to severe acute respiratory syndrome coronavirus 2 (substance)
Antibody to SARS-CoV-2
20200131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
260373001
Detected (qualifier value)
Detected
20020131
CV19-INV-InvestigationProcedures
Intensional Definition:
< 386053000 |Evaluation procedure (procedure)| OR < 308335008 |Patient encounter procedure (procedure)| OR < 17636008 |Specimen collection (procedure)|
CV19-INV-InvestigationFindings
Intensional Definition:
< 313333008 |Sample obtained (situation)| OR < 168123008 |Sample sent for examination (situation)|

20140131
60170009
169069000
840536004
419984006
Preventing the potential spread of COVID-19 can involve a range of precautions, such as isolation and the wearing of personal protective equipment, and education to patients, healthcare workers and the broader community. Once COVID-19 is diagnosed, various treatments may be considered, together with education for the patient and their families/caregivers
Prevention
Prevention Findings
Education
Medication
Administrative Procedures
Therapeutic Procedures
Treatment Findings
Treatment Equipment
These data elements are described below, with example SNOMED CT subsets where applicable.
Precautionary measures, such as , , and are extremely important in the fight against infectious diseases such as COVID-19. The following preventative measures can be recorded using SNOMED CT.
CV19-PTE-PreventionProcedures
Clinical findings (or situations) relating to the COVID-19 preventative measures performed may be captured in a health record. The following prevention findings (or situations) may be recorded using SNOMED CT.
CV19-PTE-PreventionFindings
Education is an important aspect of preventing and managing COVID-19 infection. The following SNOMED CT concepts may be used to record this data.
CV19-PTE-Education
A number of countries are trialling the use of medication to treat COVID-19. Many of these medications can be found in the hierarchy of SNOMED CT. However until there is sufficient evidence, the WHO is cautioning against associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. For this reason, we have not included a medication treatment subset at this time.
COVID-19 vaccines, however, have been proven to be effective in clinical trials. The following generic vaccine concepts may be recorded using SNOMED CT.
CV19-PTE-Vaccines
Patients with severe symptoms or complications may require admission to hospital, or other administrative procedures. The following administrative procedures may be recorded using SNOMED CT.
CV19-PTE-AdministrativeProcedures
Patients suffering from severe COVID-19 symptoms or complications may require a range of therapeutic procedures, many of them involving supportive care to help them breathe. The following therapeutic procedures may be recorded using SNOMED CT.
CV19-PTE-TherapeuticProcedures
Clinical findings relating to the treatment performed on a patient may be captured in a health record. The following treatment findings may be recorded using SNOMED CT.
CV19-PTE-TreatmentPreventionFindings
Respiratory equipment includes those medical devices used to support breathing and respiratory function - for example , and .
Footnotes
1 , IFIC Basic Concepts of Infection Control (Chapter 6), 3rd edition, 2016, International Federation of Infection Control
2
Administration of first dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
Administration of first dose of SARS-CoV-2 mRNA vaccine
20210131
1157197009
Administration of second dose of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Administration of second dose of inactivated whole SARS-CoV-2 antigen vaccine
20210731
1157108008
Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
Administration of second dose SARS-CoV-2 non-replicating viral vector vaccine
20210731
1144998002
Administration of second dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
Administration of second dose of SARS-CoV-2 mRNA vaccine
20210131
1162646009
Administration of second dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)
Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccine
20210731
1156257007
Administration of vaccine product against Severe acute respiratory syndrome coronavirus 2 (procedure)
Administration of SARS-CoV-2 vaccine
20210731
1157107003
Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
Administration of SARS-CoV-2 non-replicating viral vector vaccine
20210731
840534001
Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Administration of SARS-CoV-2 antigen vaccine
20210131
1119350007
Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
Administration of SARS-CoV-2 mRNA vaccine
20210131
1162645008
Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)
Administration of SARS-CoV-2 recombinant spike protein antigen vaccine
20210731
409524006
Airborne precautions (procedure)
Airborne precautions
20040731
422181004
Antibiotic prophylaxis (procedure)
Antibiotic prophylaxis
20060731
449399005
Application of personal protective equipment (procedure)
Application of personal protective equipment
20110731
386242000
Communicable disease management (procedure)
Communicable disease management
20030131
225368008
Contact tracing (procedure)
Contact tracing
20020131
409529001
Contact precautions (procedure)
Contact precautions
20040731
409686004
Disinfecting of equipment (procedure)
Disinfecting of equipment
20040731
449390009
Ensuring use of supplies and equipment within safe parameters (procedure)
Ensuring use of supplies and equipment within safe parameters
20110731
122467006
Fitting procedure (procedure)
Fitting procedure
20020131
77248004
Infection control procedure (procedure)
Infection control procedure
20020131
370832005
Initiation of traffic control (procedure)
Initiation of traffic control
20020731
361235007
Isolation of infected patient (procedure)
Isolation of infected patient
20020131
170499009
Isolation of infection contact (procedure)
Isolation of infection contact
20020131
170500000
Isolation of infection carrier (procedure)
Isolation of infection carrier
20020131
40174006
Isolation procedure (procedure)
Isolation technique
20020131
225995005
Maintaining a safe environment (procedure)
Maintaining a safe environment
20020131
275827007
Maintaining asepsis (procedure)
Maintaining asepsis
20020131
38883000
Preoperative disinfection of skin (procedure)
Preoperative disinfection of skin
20020131
29537000
Preoperative shaving of skin (procedure)
Preoperative shaving of skin
20080131
736762004
Provision of personal protective equipment (procedure)
Provision of personal protective equipment
20180131
409525007
Respiratory secretion precautions (procedure)
Respiratory secretion precautions
20040731
410410006
Screening surveillance (regime/therapy)
Screening surveillance
20040731
409522005
Standard precautions (procedure)
Standard precautions
20040731
409684001
Sterilization of equipment (procedure)
Sterilization of equipment
20040731
409583003
Transmission-based precautions (procedure)
Transmission-based precautions
20040731
243791004
Viral screening (procedure)
Viral screening
20080131
Adverse reaction to component of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (disorder)
Adverse reaction to inactivated whole COVID-19 antigen vaccine
20210731
1157106007
Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (disorder)
Adverse reaction to COVID-19 non-replicating viral vector vaccine
20210731
1142182006
Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (disorder)
Adverse reaction to COVID-19 antigen vaccine
20210131
1142181004
Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (disorder)
Adverse reaction to COVID-19 mRNA vaccine
20210131
1162644007
Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (disorder)
Adverse reaction to COVID-19 recombinant spike protein antigen vaccine
20210731
1145003007
Hypersensitivity to vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (finding)
Hypersensitivity to SARS-CoV-2 mRNA vaccine
20210131
1157198004
Inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)
Inactivated whole SARS-CoV-2 antigen vaccine contraindicated
20210731
1157200005
Inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)
Inactivated whole SARS-CoV-2 antigen vaccine declined
20210731
1157199007
Second dose of inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)
Second dose of inactivated whole SARS-CoV-2 antigen vaccine contraindicated
20210731
1157201009
Second dose of inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)
Second dose of inactivated whole SARS-CoV-2 antigen vaccine declined
20210731
1145035007
Second dose of Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (situation)
Second dose of SARS-CoV-2 mRNA vaccine contraindicated
20210131
1145034006
Second dose of Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)
Second dose of SARS-CoV-2 mRNA vaccine declined
20210131
1157113007
Second dose of Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (situation)
Second dose of SARS-CoV-2 non-replicating viral vector vaccine contraindicated
20210731
1157120000
Second dose of Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (situation)
Second dose of SARS-CoV-2 non-replicating viral vector vaccine declined
20210731
1162648005
Second dose of Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (situation)
Second dose of recombinant spike protein SARS-CoV-2 antigen vaccine contraindicated
20210731
1162650002
Second dose of Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (situation)
Second dose of SARS-CoV-2 recombinant spike protein antigen vaccine declined
20210731
1145031003
Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)
SARS-CoV-2 vaccine declined
20210131
1145023008
Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)
SARS-CoV-2 antigen vaccine contraindicated
20210131
1145033000
Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)
SARS-CoV-2 antigen vaccine declined
20210131
1145030002
Severe acute respiratory syndrome coronavirus 2 antigen vaccination not indicated (situation)
SARS-CoV-2 antigen vaccination not indicated
20210131
1145022003
Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (situation)
SARS-CoV-2 mRNA vaccine contraindicated
20210131
1145032005
Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)
SARS-CoV-2 mRNA vaccine declined
20210131
1145029007
Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (situation)
SARS-CoV-2 mRNA vaccination not indicated
20210131
1157110005
Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (situation)
SARS-CoV-2 non-replicating viral vector vaccine contraindicated
20210731
1157118003
Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (situation)
SARS-CoV-2 non-replicating viral vector vaccine declined
20210731
1162647000
Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (situation)
SARS-CoV-2 recombinant spike protein antigen vaccine contraindicated
20210731
1162649002
Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (situation)
SARS-CoV-2 recombinant spike protein antigen vaccine declined
20210731
1156270003
Severe acute respiratory syndrome coronavirus 2 vaccination declined (situation)
SARS-CoV-2 vaccination declined
20210731
1156267002
Severe acute respiratory syndrome coronavirus 2 vaccination not indicated (situation)
SARS-CoV-2 vaccination not indicated
20210731
1156265005
Severe acute respiratory syndrome coronavirus 2 vaccine contraindicated (situation)
SARS-CoV-2 vaccine contraindicated
20210731
1156746003
Vaccine-induced prothrombotic immune thrombocytopenia (disorder)
Vaccine-induced prothrombotic immune thrombocytopenia
20210731
Education about infectious disease (procedure)
Education about infectious disease
20200731
223426009
Equipment use education (procedure)
Equipment use education
20020131
698608004
Hand washing education (procedure)
Hand washing education
20140131
385820004
Infection control education (procedure)
Infection control education
20100731
Vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)
Inactivated whole SARS-CoV-2 antigen vaccine
20210731
29061000087103
Vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (medicinal product)
COVID-19 non-replicating viral vector vaccine
20210731
1119305005
Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)
Severe acute respiratory syndrome coronavirus 2 antigen only vaccine product
20210131
1119349007
Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)
Severe acute respiratory syndrome coronavirus 2 mRNA only vaccine product
20210131
1162643001
Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product)
SARS-CoV-2 recombinant spike protein antigen vaccine
20210731
Admission to infectious diseases department (procedure)
Admission to infectious diseases department
20020131
305351004
Admission to intensive care unit (procedure)
Admission to intensive care unit
20020131
305360007
Admission to respiratory medicine department (procedure)
Admission to respiratory medicine department
20020131
32485007
Hospital admission (procedure)
Hospital admission
20020131
417005
Hospital re-admission (procedure)
Hospital re-admission
20020131
107724000
Patient transfer (procedure)
Patient transfer
20020131
397821002
Patient transfer to intensive care unit (procedure)
Patient transfer to intensive care unit
20030731
710112000
Transfer of care from hospital (procedure)
Transfer of care from hospital
20150731
429202003
Transfer of care to hospital (procedure)
Transfer of care to hospital
20080131
Extracorporeal membrane oxygenation (procedure)
Extracorporeal membrane oxygenation
20020131
697984004
Exteriorization of trachea (procedure)
Exteriorization of trachea
20140131
229301009
Incentive spirometry (regime/therapy)
Incentive spirometry
20020131
829831000000100
Insertion of fiducial marker into lung using computed tomography guidance (procedure)
Insertion of fiducial marker into lung using computed tomography guidance
20200731
447996002
Intubation of respiratory tract (procedure)
Intubation of respiratory tract
20110731
243141005
Mechanically assisted spontaneous ventilation (procedure)
Mechanically assisted spontaneous ventilation
20020131
428311008
Noninvasive ventilation (procedure)
Noninvasive ventilation
20080131
371908008
Oxygen administration by mask (procedure)
Oxygen administration by mask
20020731
371907003
Oxygen administration by nasal cannula (procedure)
Oxygen administration by nasal cannula
20020731
431182000
Placing subject in prone position (procedure)
Placing subject in prone position
20080731
11140008
Respiratory assist, manual (procedure)
Respiratory assist, manual
20020131
1156748002
Transfusion of convalescent plasma into central vein (procedure)
Transfusion of convalescent plasma into central vein
20210731
1156747007
Transfusion of convalescent plasma into peripheral vein (procedure)
Transfusion of convalescent plasma into peripheral vein
20210731
Dependence on supplemental oxygen (finding)
Dependence on supplemental oxygen
20120731
444932008
Dependence on ventilator (finding)
Dependence on ventilator
20100731
763326004
Difficult mask ventilation (finding)
Difficult mask ventilation
20180731
718447001
Difficult tracheal intubation (finding)
Difficult intubation
20160731
419991009
Endotracheal tube present (finding)
Endotracheal tube present
20060131
405496006
Inability to ventilate patients lungs mechanically (finding)
Inability to ventilate patients lungs mechanically
20040131
22803001
Normal respiratory function (finding)
Normal respiratory function
20020131
371825009
Patient on oxygen (finding)
Patient on oxygen
20020731
371820004
Patient ventilated (finding)
Patient ventilated
20020731
718085007
Unable to intubate and unable to ventilate (finding)
Cannot intubate cannot ventilate
20160731
128258000
Ventilation finding (finding)
Ventilation finding
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
1157196000
Administration of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Administration of inactivated whole SARS-CoV-2 antigen vaccine
20210731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
1156256003
Adverse reaction to component of vaccine product against Severe acute respiratory syndrome coronavirus 2 (disorder)
Adverse reaction to COVID-19 vaccine
20210731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
736017006
Education about hand hygiene (procedure)
Education about hand hygiene
20180131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
28531000087107
Vaccine product against Severe acute respiratory syndrome coronavirus 2 (medicinal product)
COVID-19 vaccine
20210731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
183452005
Emergency hospital admission (procedure)
Emergency hospital admission
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
40617009
Artificial respiration (procedure)
Artificial respiration
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
79031000119101
Dependence on respirator (finding)
Dependence on respirator
20150731
CV19-PTE-TreatmentEquipment
Intensional Definition:
< 277973009 |Respiratory equipment (physical object)| OR < 336589003 |Oxygen equipment (physical object)| OR < 334943003 |Respiratory appliances (physical object)| OR < 304077006 |Respiratory system device (physical object)| OR < 706167001 |Anesthesia and respiratory device (physical object)|

1144997007
1157195001
868263005
1157024006
305376003
233573008
931000119107
The first step in delivering comprehensive care is to undertake a clinical assessment. Clinical assessment data which can be recorded using SNOMED CT includes:
Symptoms
Severity
Clinical Measurements
Clinical Examination Findings
Diagnosis and Certainty
Clinical History
Secondary Conditions and Complications
Potential Risk Factors
Comorbidities
Exposure Event
Covid-19 and Viral Co-Infections
These data elements are described below, with example SNOMED CT subsets for each.
Please note that all published concepts referred to on this page are included in SNOMED International's , which is available to be used internationally under the . Please refer to for more information.
Symptoms represent physical or mental features which are regarded as an indication of a condition or disease, particularly those features that are apparent to the patient. This SNOMED CT subset of COVID-19 symptoms has been developed based on a range of literature, including relevant articles found in Pubmed, research performed by Kings College London, and a review of COVID-19 data collection forms. Please note that this subset includes the concept , which can be used to represent the absence of symptoms.
CV19-ASS-Symptoms
Severity represents the quality of the condition - for example, . Severity may be recorded for each symptom, or as a general statement of their disease state 4.
CV19-ASS-Severity
Clinical measurements involve the performance of physiological tests to diagnose and refine therapeutic management of an already established disease. The following clinical measurements (and related observables) can be used in the assessment of a COVID-19 patient.
CV19-ASS- ClinicalMeasurements
Clinical examination findings are the result of measuring, questioning, evaluating, or otherwise examining a patient in healthcare. The following clinical findings are positive or negative indications that signs are present in a COVID-19 patient.
CV19-ASS-ClinicalExaminationFindings
A diagnosis is the identification of the nature of the illness, based on an examination of the symptoms, observations, measurements, test results and other investigation results. The following subset includes a range of diagnoses directly related to COVID-19.
CV19-ASS-Diagnosis
To represent the certainty of a positive COVID-19 diagnosis, the following subset may be used in conjunction with a diagnosis of .
CV19-ASS-DiagnosisPresentCertainty
To represent the certainty of the absence of COVID-19, the following subset may be used in conjunction with a diagnosis of .
CV19-ASS-DiagnosisAbsentCertainty
The clinical history concepts are used to record information gained by a physician by asking specific questions, either of the patient or of other people who know the person and can give suitable information, with the aim of obtaining information useful in formulating a diagnosis and providing medical care to the patient.
CV19-ASS-ClinicalHistory
A secondary condition is any additional health condition that occurs as a result of the natural progression or expected outcome of the primary condition. A complication is "a disorder caused by another disorder, procedure or event, which is not a natural progression or expected outcome of its cause .
The following subset includes SNOMED CT clinical findings that may be recorded as either secondary conditions or complications . Clinical judgement is required to determine whether these conditions are expected outcomes or unexpected complications of COVID-19.
CV19-ASS-SecondaryConditionsAndComplications
Potential risk factors are the patient conditions which may influence the course or outcomes of the COVID-19 disease. The following clinical findings may be recorded as potential risk factors.
CV19-ASS-RiskFactors
Similarly, procedures performed on the patient within a clinically relevant timeframe may also influence the course or outcomes of the COVID-19 disease. The following procedures may be recorded as potential risk factors.
CV19-ASS-ProcedureRiskFactors
Comorbidities are additional medical conditions of concern. The following SNOMED CT subset can be used to record comorbidities.
An exposure event is when an individual comes into close contact with an infected person's contaminated droplets, carried in the air or on contaminated hands, surfaces or other objects. The subset below includes SNOMED CT events for recording exposure to COVID-19.
CV19-ASS-ExposureEvent
An exposure finding is the result of an observation or evaluation that relates to the patient's exposure to an infection. The subset below includes SNOMED CT findings relating to COVID-19 exposure.
CV19-ASS-ExposureFinding
The following organism should be used when recording the organism causing COVID-19 infections.
CV19-ASS-Organism
The following organisms can be used to record the cause of related viral co-infections.
Footnotes
1 Articles found using the Pubmed query ""
2
3 COVID-19 Case Reporting Forms, including: , CDC, US , Global COVID-19 Clinical Platform, World Health Organization , NHS, UK
4 , Patient.info , Patient.info
5 , SNOMED International
6 Clinical papers, including:
7
8 , NHS, UK
9 , NHS, UK
Bleeding (finding)
Bleeding
20050131
29857009
Chest pain (finding)
Chest pain
20040731
43724002
Chill (finding)
Chill
20020131
82272006
Common cold (disorder)
Common cold
20030131
9826008
Conjunctivitis (disorder)
Conjunctivitis
20040731
49727002
Cough (finding)
Cough
20020131
3415004
Cyanosis (finding)
Cyanosis
20020131
62315008
Diarrhea (finding)
Diarrhea
20020131
3006004
Disturbance of consciousness (finding)
Disturbance of consciousness
20020131
267036007
Dyspnea (finding)
Dyspnea
20020131
271807003
Eruption of skin (disorder)
Eruption
20020731
84229001
Fatigue (finding)
Fatigue
20020131
103001002
Feeling feverish (finding)
Feeling feverish
20020131
386661006
Fever (finding)
Fever
20030131
25064002
Headache (finding)
Headache
20100131
66857006
Hemoptysis (finding)
Hemoptysis
20020131
248567008
Indrawing of ribs during respiration (finding)
Indrawing of ribs during respiration
20020131
57676002
Joint pain (finding)
Joint pain
20020131
79890006
Loss of appetite (finding)
Loss of appetite
20020131
44169009
Loss of sense of smell (finding)
Loss of sense of smell
20200131
36955009
Loss of taste (finding)
Loss of taste
20020131
30746006
Lymphadenopathy (disorder)
Lymphadenopathy
20020131
367391008
Malaise (finding)
Malaise
20020131
68962001
Muscle pain (finding)
Muscle pain
20020131
26544005
Muscle weakness (finding)
Muscle weakness
20020131
68235000
Nasal congestion (finding)
Nasal congestion
20020131
64531003
Nasal discharge (finding)
Nasal discharge
20020131
422587007
Nausea (finding)
Nausea
20070131
44077006
Numbness (finding)
Numbness
20170731
162397003
Pain in throat (finding)
Pain in throat
20020131
38880002
Rigor (finding)
Rigor
20020131
91175000
Seizure (finding)
Seizure
20020131
46742003
Skin ulcer (disorder)
Skin ulcer
20020131
23924001
Tight chest (finding)
Tight chest
20020131
282145008
Unable to walk (finding)
Unable to walk
20080731
422400008
Vomiting (disorder)
Vomiting
20180731
56018004
Wheezing (finding)
Wheezing
20020131
Moderate (severity modifier) (qualifier value)
Moderate
20020131
24484000
Severe (severity modifier) (qualifier value)
Severe
20020131
442452003
Life threatening severity (qualifier value)
Life threatening severity
20090731
Body temperature (observable entity)
Body temperature
20170131
75367002
Blood pressure (observable entity)
Blood pressure
20170131
248592006
Character of cough (observable entity)
Character of cough
20020131
364533002
Color of skin (observable entity)
Color of skin
20020131
709017009
Compliance behavior to safety precaution (observable entity)
Compliance behavior to safety precaution
20150731
263731006
Coughing (observable entity)
Coughing
20020131
271626009
Depth of respiration (observable entity)
Depth of respiration
20020131
226379006
Food intake (observable entity)
Food intake
20020131
364075005
Heart rate (observable entity)
Heart rate
20170131
103228002
Hemoglobin saturation with oxygen (observable entity)
Hemoglobin saturation with oxygen
20020131
6942003
Level of consciousness (observable entity)
Level of consciousness
20020131
440398005
Level of fatigue (observable entity)
Level of fatigue
20090131
405161002
Pain level (observable entity)
Pain level
20040131
248750004
Peripheral blood flow (observable entity)
Peripheral blood flow
20020131
431314004
Peripheral oxygen saturation (observable entity)
Peripheral oxygen saturation
20080731
8499008
Pulse, function (observable entity)
Pulse
20020131
248565000
Respiratory effort (observable entity)
Respiratory effort
20020131
86290005
Respiratory rate (observable entity)
Respiratory rate
20170131
248582003
Rhythm of respiration (observable entity)
Rhythm of respiration
20020131
247433003
Skin elasticity (observable entity)
Skin elasticity
20020131
248598005
Sputum volume (observable entity)
Sputum volume
20020131
442349007
Venous oxygen saturation (observable entity)
Venous oxygen saturation
20090731
Activity intolerance (finding)
Activity intolerance
20020131
20262006
Ataxia (finding)
Ataxia
20020131
371632003
Coma (disorder)
Coma
20020731
193894004
Conjunctival hyperemia (finding)
Conjunctival hyperemia
20100131
58840004
Decreased breath sounds (finding)
Decreased breath sounds
20020131
443371007
Decreased level of consciousness (finding)
Decreased level of consciousness
20100131
9763007
Expiratory wheezing (finding)
Expiratory wheezing
20020131
126664009
Exudative pharyngitis (disorder)
Exudative pharyngitis
20020131
386661006
Fever (finding)
Fever
20030131
442646005
Imaging of lung abnormal (finding)
Imaging of lung abnormal
20090731
67750007
Ineffective airway clearance (finding)
Ineffective airway clearance
20020131
70944005
Impaired gas exchange (finding)
Impaired gas exchange
20080731
75252003
Inspiratory crackles (finding)
Inspiratory crackles
20020131
419045004
Loss of consciousness (finding)
Loss of consciousness
20060131
274710003
Lung field abnormal (finding)
Lung field abnormal
20020131
91175000
Seizure (finding)
Seizure
20020131
3424008
Tachycardia (finding)
Tachycardia
20080731
271823003
Tachypnea (finding)
Tachypnea
20020131
288849009
Unable to breathe (finding)
Unable to breathe
20080731
Asymptomatic severe acute respiratory syndrome coronavirus 2 infection (finding)
Asymptomatic SARS-CoV-2
20200731
840539006
Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
COVID-19
20200131
688232241000119100
Disease caused by Severe acute respiratory syndrome coronavirus 2 absent (situation)
Disease caused by Severe acute respiratory syndrome coronavirus 2 absent
20200731
840544004
Suspected disease caused by severe acute respiratory coronavirus 2 (situation)
Suspected COVID-19
20200131
Probably present (qualifier value)
Probably present
20040731
415684004
Suspected (qualifier value)
Suspected
20050131
Probably NOT present (qualifier value)
Probably NOT present
20040731
Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
870589006
Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
373895009
Acute respiratory distress (finding)
Acute respiratory distress
20020731
67782005
Acute respiratory distress syndrome (disorder)
Acute respiratory distress syndrome
20020131
674814021000119106
Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
64779008
Blood coagulation disorder (disorder)
Blood coagulation disorder
20020731
119731000146105
Cardiomyopathy due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Cardiomyopathy due to disease caused by Severe acute respiratory syndrome virus 2
20200731
62914000
Cerebrovascular disease (disorder)
Cerebrovascular disease
20020131
1119304009
Chronic post-COVID-19 syndrome (disorder)
Chronic post-COVID-19 syndrome
20210131
119741000146102
Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
710027002
Cytokine-associated toxicity (disorder)
Cytokine release syndrome
20150731
419099009
Dead (finding)
Dead
20060131
128053003
Deep venous thrombosis (disorder)
Deep venous thrombosis
20020131
34095006
Dehydration (disorder)
Dehydration
20020131
67406007
Disseminated intravascular coagulation (disorder)
Disseminated intravascular coagulation
20020131
3006004
Disturbance of consciousness (finding)
Disturbance of consciousness
20020131
119981000146107
Dyspnea caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Dyspnea caused by Severe acute respiratory syndrome coronavirus 2
20200731
1240561000000108
Encephalopathy due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Encephalopathy due to disease caused by Severe acute respiratory syndrome virus 2
20200731
119751000146104
Fever caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Fever caused by Severe acute respiratory syndrome coronavirus 2
20200731
25374005
Gastroenteritis (disorder)
Gastroenteritis
20020131
56265001
Heart disease (disorder)
Heart disease
20020131
80394007
Hyperglycemia (disorder)
Hyperglycemia
20020131
389086002
Hypoxia (disorder)
Hypoxia
20030131
70944005
Impaired gas exchange (finding)
Impaired gas exchange
20080731
1240541000000107
Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2
20200731
90708001
Kidney disease (disorder)
Kidney disease
20020731
880529761000119102
Lower respiratory infection caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Lower respiratory infection caused by SARS-CoV-2
20200731
866151004
Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)
Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2
20200731
59455009
Metabolic acidosis (disorder)
Metabolic acidosis
20020131
57653000
Multiple organ failure (disorder)
Multiple organ failure
20020131
1240531000000103
Myocarditis due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Myocarditis due to disease caused by Severe acute respiratory syndrome virus 2
20200731
1240521000000100
Otitis media due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)
Otitis media due to disease caused by Severe acute respiratory syndrome virus 2
20200731
183676005
Died in hospital (finding)
Died in hospital
20020131
882784691000119100
Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Pneumonia caused by SARS-CoV-2
20200731
1119303003
Post-acute COVID-19 (disorder)
Post-acute COVID-19
20210131
870591003
Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
302846007
Rhabdomyoma (disorder)
Rhabdomyoma
20040731
308906005
Secondary bacterial pneumonia (disorder)
Secondary bacterial pneumonia
20160131
91302008
Sepsis (disorder)
Sepsis
20200131
870588003
Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2
20200731
76571007
Septic shock (disorder)
Septic shock
20050131
415623008
Stress ulcer (disorder)
Stress ulcer
20050131
238149007
Systemic inflammatory response syndrome (disorder)
Systemic inflammatory response syndrome
20020131
866152006
Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)
Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2
20200731
429340002
Traumatic injury of skeletal muscle (disorder)
Traumatic injury of skeletal muscle
20080131
75570004
Viral pneumonia (disorder)
Viral pneumonia
20130731
1017214008
Viremia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
SARS-CoV-2 viremia
20210131
Chronic disease (disorder)
Chronic disease
20020131
49601007
Disorder of cardiovascular system (disorder)
Disorder of cardiovascular system
20020131
414029004
Disorder of immune function (disorder)
Disorder of immune function
20190131
235856003
Disorder of liver (disorder)
Disorder of liver
20020131
118940003
Disorder of nervous system (disorder)
Disorder of nervous system
20020131
50043002
Disorder of respiratory system (disorder)
Disorder of respiratory system
20020131
722499006
Electronic cigarette user (finding)
Electronic cigarette user
20170131
8517006
Ex-smoker (finding)
Ex-smoker
20020131
80141007
Hemoglobinopathy (disorder)
Hemoglobinopathy
20020131
107921000119107
History of immune disorder (situation)
History of immune disorder
20150731
90708001
Kidney disease (disorder)
Kidney disease
20020731
363346000
Malignant neoplastic disease (disorder)
Malignant neoplastic disease
20020131
75934005
Metabolic disease (disorder)
Metabolic disease
20020131
414825006
Neoplasm of hematopoietic cell type (disorder)
Neoplasm of hematopoietic cell type
20050131
414915002
Obese (finding)
Obese
20050131
370388006
Patient immunocompromised (finding)
Patient immunocompromised
20020731
370391006
Patient immunosuppressed (finding)
Patient immunosuppressed
20020731
77386006
Pregnant (finding)
Pregnant
20020131
77176002
Smoker (finding)
Smoker
20020131
Corticosteroid and corticosteroid derivative therapy (procedure)
Corticosteroid and corticosteroid derivative therapy
20200131
234336002
Hemopoietic stem cell transplant (procedure)
Hemopoietic stem cell transplant
20050131
86553008
Immunosuppressive therapy (procedure)
Immunosuppressive therapy
20020131
76334006
Immunotherapy (procedure)
Immunological therapy
20020131
108290001
Radiation oncology AND/OR radiotherapy (procedure)
Radiation oncology AND/OR radiotherapy
20020131
312235007
Radiolabeled antibody therapy (procedure)
Radiolabeled antibody therapy
20020131
265764009
Renal dialysis (procedure)
Renal dialysis
20020131
313039003
Solid organ transplant (procedure)
Solid organ transplant
20060731
Occupational exposure to Severe acute respiratory syndrome coronavirus 2 (event)
Occupational exposure to SARS-CoV-2
20210131
21522001
Abdominal pain (finding)
Abdominal pain
20050131
84387000
Asymptomatic (finding)
Asymptomatic
20020131
84387000
Asymptomatic (finding)
Asymptomatic
20020131
255604002
Mild (qualifier value)
Mild
20020131
413384008
Ability to perform cognitive activity (observable entity)
Ability to perform cognitive activity
20050131
442476006
Arterial oxygen saturation (observable entity)
Arterial oxygen saturation
20090731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
288848001
Able to breathe (finding)
Able to breathe
20080731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
1119302008
Acute disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
Acute COVID-19
20210131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
410605003
Confirmed present (qualifier value)
Confirmed present
20040731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
410594000
Definitely NOT present (qualifier value)
Definitely NOT present
20040731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
In GPS
292508471000119105
History of disease caused by severe acute respiratory syndrome coronavirus 2 (situation)
History of SARS-CoV-2
20200731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
138389411000119105
Acute bronchitis caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Acute bronchitis caused by SARS-CoV-2
20200731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
78648007
At risk for infection (finding)
At risk for infection
20020131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
367336001
Chemotherapy (procedure)
Chemotherapy
20020131
CV19-ASS-Comorbidities
Intensional Definition:
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
840546002
Exposure to severe acute respiratory syndrome coronavirus 2 (event)
Exposure to SARS-CoV-2
20200131
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
870577009
At increased risk of exposure to severe acute respiratory syndrome coronavirus 2 (finding)
At increased risk of exposure to severe acute respiratory syndrome coronavirus 2
20200731
Concept id
Fully Specified Name
en-US Preferred Term
Effective Time
840533007
Severe acute respiratory syndrome coronavirus 2 (organism)
SARS-CoV-2
20200131
CV19-ASS-ViralCoInfections
Intensional Definition:
<< 49872002 |Virus (organism)| MINUS 840533007 |Severe acute respiratory syndrome coronavirus 2 (organism)|

131148009
6736007
386725007
77427003
189486241000119100
410592001
410593006
-
870590002
27624003
788751009
897036007